ArticleJournal of translational medicine2021
Ibrutinib protects T cells in patients with CLL from proliferation-induced senescence.
Joanne E Davis et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
18 papers cite it
this papertrialcites it